×
ClearPoint Neuro Total Long-Term Assets 2010-2024 | CLPT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
ClearPoint Neuro total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
View More
ClearPoint Neuro Total Long-Term Assets 2010-2024 | CLPT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
ClearPoint Neuro total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.1B
Intuitive Surgical (ISRG)
$171.3B
Alcon (ALC)
$47.7B
IQVIA Holdings (IQV)
$44.2B
IDEXX Laboratories (IDXX)
$42.1B
Edwards Lifesciences (EW)
$40.7B
DexCom (DXCM)
$27.8B
STERIS (STE)
$23.5B
SONOVA HOLDING (SONVY)
$20.8B
Waters (WAT)
$19.8B
Hologic (HOLX)
$19B
Sysmex ADR (SSMXY)
$12.3B
Fresenius Medical Care AG KGaA (FMS)
$12.2B
Teleflex (TFX)
$11.4B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.6B
Glaukos (GKOS)
$6.7B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5.2B
PROCEPT BioRobotics (PRCT)
$4.3B
Integer Holdings (ITGR)
$4.3B
Tandem Diabetes Care (TNDM)
$2.8B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.6B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.6B
Nihon Kohden (NHNKY)
$2.5B
RxSight (RXST)
$2B
Integra LifeSciences Holdings (IART)
$1.4B
Pulse Biosciences (PLSE)
$1.2B